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Abstract 
Background: The breast and ovarian cancer susceptibility gene BRCA1 encodes a multifunctional tumor suppres-
sor protein BRCA1, which is involved in regulating cellular processes such as cell cycle, transcription, DNA repair, DNA 
damage response and chromatin remodeling. BRCA1 protein, located primarily in cell nuclei, interacts with multiple 
proteins and various DNA targets. It has been demonstrated that BRCA1 protein binds to damaged DNA and plays a 
role in the transcriptional regulation of downstream target genes. As a key protein in the repair of DNA double-strand 
breaks, the BRCA1-DNA binding properties, however, have not been reported in detail.
Results: In this study, we provided detailed analyses of BRCA1 protein (DNA-binding domain, amino acid residues 
444–1057) binding to topologically constrained non-B DNA structures (e.g. cruciform, triplex and quadruplex). Using 
electrophoretic retardation assay, atomic force microscopy and DNA binding competition assay, we showed the 
greatest preference of the BRCA1 DNA-binding domain to cruciform structure, followed by DNA quadruplex, with the 
weakest affinity to double stranded B-DNA and single stranded DNA. While preference of the BRCA1 protein to cruci-
form structures has been reported previously, our observations demonstrated for the first time a preferential binding 
of the BRCA1 protein also to triplex and quadruplex DNAs, including its visualization by atomic force microscopy.
Conclusions: Our discovery highlights a direct BRCA1 protein interaction with DNA. When compared to dou-
ble stranded DNA, such a strong preference of the BRCA1 protein to cruciform and quadruplex structures sug-
gests its importance in biology and may thus shed insight into the role of these interactions in cell regulation and 
maintenance.
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Background
The BRCA1 protein is encoded by the tumor suppressor 
gene BRCA1, mutation in which occurs often in breast 
and ovarian cancer patients [1]. This multifunctional 
protein plays critical roles in different cellular pathways 
including cell cycle, transcription, DNA repair, DNA 
damage response and chromatin remodeling [2–4]. 
BRCA1 is a large phosphoprotein of 1863 amino acid 
residues (aa) and it is located primarily in cell nuclei. 
One of the key functions of BRCA1 protein is its ability 
to modulate multiple protein–protein and protein-DNA 
interactions. Despite the enormous molecular weight of 
BRCA1 protein, only two small conserved domains have 
been identified: ring finger motif (RING) at the N-termi-
nus and two tandem BRCT repeats at the C-terminus. 
The central region of BRCA1 protein is largely unfolded, 
but it has been demonstrated to act as a scaffold to inter-
acts directly with proteins and DNA [5]. It was deter-
mined that BRCA1 protein binds also to damaged DNA 
and regulates downstream target genes transcriptionally 
[6]. Moreover, previous studies have shown preferential 
binding of BRCA1 to cruciform [7], branch point [8] and 
superhelical [9] DNAs, highlighting the important rela-
tionship of BRCA1 protein with non-B DNA structures.
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Non-B DNA structures are present in all living organ-
isms [10] and are constantly been remodeled during pro-
cesses such as DNA replication, transcription and repair. 
Local nucleotide sequence-dependent conformational 
changes, which give rise to cruciform, left-handed DNA, 
triplex and quadruplex structures, could all be stabilized 
further by negative supercoiling [11–13]. These non-B 
DNA structures can be recognized and stabilized also by 
various proteins, resulting in modulation of transcription 
[14], replication [15], junction resolving [16] and chro-
matin remodeling [17]. Cruciform structure, which origi-
nates from inverted repeats of variable length, plays key 
roles in replication and transcription [18, 19] and is a tar-
get for many essential proteins [20] including the human 
tumor suppressor proteins p53 [21, 22] and BRCA1 [23]. 
Triplex DNA, consisting of Watson–Crick and Hoog-
sten base-pairing, is formed by mirror repeats of homu-
purine-homopyrimidine sequences [24]. G-quadruplex 
DNA, as the name implies, arises from a G-rich sequence 
and forms a four-stranded structure through Hoogsteen 
base-pairing [25]. G-quadruplex structures were first 
characterized in vitro, but have nowadays been shown to 
exist in vivo using G-quadruplex stabilizing compounds 
[26] and specific G-quadruplex antibody [27]. The 
increased interest in G-quadruplexes stems from the high 
abundance of potential G-quadruplex-forming sequences 
in both eukaryotic and prokaryotic genomes (for reviews 
see ref: [28, 29]). In addition, the prevalence of G-quad-
ruplexes in promoter regions and telomeres further 
reveals the significance of such structures in the genome.
It has been illustrated by microarray analysis that 
BRCA1 protein regulates the expression of a broad vari-
ety of genes [30]. Although upregulation of BRCA1 pro-
tein leads to drastic changes in transcription of gene 
targets, the mechanism remains unclear. Several studies 
have shown that the central region of BRCA1 is capable 
of interacting with DNA including short double-stranded 
oligonucleotide and long supercoiled DNA [7, 9, 23]. 
Additional findings further revealed BRCA1 protein’s 
selectivity for four-way junction DNA over linear duplex 
DNA [23, 31]. It is therefore likely that BRCA1 exerts its 
regulation by been able to recognize and bind DNA tar-
gets with different conformations directly.
Here we analyzed the binding of BRCA1 protein to vari-
ous DNA targets with B- and non B-DNA conformations. 
Using gel shift assay, magnetic beads immunoprecipitation 
and atomic force microscopy (AFM), we demonstrated a 
strong preference of the central region (aa 444–1057) of 
the BRCA1 protein to non-B DNA structures, especially to 
cruciform and quadruplex DNA structures. Our findings 
further pointed to BRCA1 protein’s potential in regulating 
cellular processes by its direct interaction with DNA struc-
tures broadly present in the genomic DNA.
Results
BRCA1‑L protein binds to different DNA targets
We analyzed the central region of BRCA1 protein (aa 
444–1057: BRCA1-L, Additional file  1: Figure S1) bind-
ing to different DNA targets in detail. We prepared five 
different DNA oligonucleotide targets (Fig. 1a) that have 
implications in transcription and other cellular processes. 
Quality and purity of these structures were identified by 
their mobility in native polyacrylamide electrophoresis in 
0.33× TBE buffer, and the formation of the G-quadruplex 
was confirmed by circular dichroism (CD) spectroscopy 
(data not shown). Due to structural changes of the DNA 
organization, the mobility of DS DNA was slower than 
that of SS DNA, as expected. The cruciform (CF) struc-
ture which is composed of 4 oligonucleotide strands dis-
played the slowest mobility followed by the quadruplex 
oligonucleotide of 51 bp. Formation of intermolecular tri-
plex structure from oligonucleotide targets required the 
presence of magnesium ions (Mg2+) in the hybridization 
buffer as well in the polyacrylamide gel. Unfortunately, 
because the presence of MgCl2 inhibited the DNA-bind-
ing properties of BRCA1-L protein (not shown), gel-shift 
assay on PAGE gel was performed only for SS, DS, Q 
and CF DNA structures. As shown in Fig. 1b, BRCA1-L 
protein was able to bind to all the tested DNA substrates 
in the DNA binding buffer. Increased concentration of 
BRCA1-L protein (BRCA1-L:DNA molar ratio from 0.5:1 
to 4:1) led to formation of retarded bands with slower 
mobility. At very low BRCA1-L/CF DNA molar ratios 
of 0.5:1 and 1:1, formation of retarded band was already 
evident (Fig. 1b, lanes 17, 18). Notably at molar ratio of 
4:1, there was a near-complete disappearance of the free 
CF DNA (Fig. 2, lane 20) indicating that almost all the CF 
DNA has been bound by BRCA1-L protein. The gel shift 
assay also showed formation of retarded complexes with 
SS, DS and Q oligonucleotides, especially at high BRCA1-
L/DNA molar ratio of 4:1 (Fig. 1b, lanes 5, 10, 15). How-
ever, lower BRCA1-L/DNA molar ratios led to formation 
of retarded band only with DS, Q and CF oligonucleo-
tides. We did not observe any gel shift with BRCA1-A 
construct which lacks the DNA binding domain (aa 219–
498, negative control, Additional file  1: Figure S2). Taken 
together, these results demonstrated that BRCA1-L, but 
not BRCA1-A protein, has a strong affinity to DNA even 
at low molar concentrations.
Preferential binding of BRCA1‑L protein to non‑B DNA 
structures in short oligonucleotides on PAGE gel
To determine the preference of BRCA1-L protein to dif-
ferent non-B DNA structures, competition assay was 
performed. BRCA1-L protein was bound to FAM-labeled 
CF structure oligonucleotides with and without differ-
ent competitor non-labeled DNAs (Fig. 2). Only a small 
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decrease in retarded band intensity was observed with 
high concentrations of SS competitor DNA, while a 
stronger decrease was seen with lower concentrations of 
quadruplex competitor DNA (Fig.  2a). Using the same 
approach, we tested also competition of BRCA1-L/CF 
complex by DS and CF competitor DNAs. The change in 
intensity of retarded bands was analyzed by densitometry 
(Fig. 2b). SS and DS DNAs were weak binding targets for 
BRCA1-L protein compare to cruciform and quadruplex 
DNAs. Even 20-fold molar excess of SS or DS B-DNA 
competitor was not able to compete with BRCA1-L com-
plex with cruciform structure (Fig. 2b, SS-black column, 
DS-dashed column). The strongest BRCA1-L-binding 
partner was cruciform structure (Fig.  2b, speckle col-
umn) followed by quadruplex oligonucleotide (Fig.  2b, 
grey column). While fivefold excess of SS or DS competi-
tor DNA decreased retarded band intensity by approxi-
mately 30  %, cruciform and quadruplex competitor 
DNAs decreased retarded band intensity by around 90 
and 72  %, respectively. Notably, a 20-fold surplus of CF 
and Q oligonucleotides led to completely ablation of 
retarded band intensity. Importantly, statistically signifi-
cant difference (p  <  0.05) between BRCA1-L binding to 
non-B DNA structures and DS was observed.
Proof of the presence of non‑B DNA structures in plasmid 
DNAs by atomic force microscopy
We used sequences that have the potential to form dif-
ferent non-B DNA structures in plasmid DNA. We 
documented in an earlier study that natural superheli-
cal density in DNA could stabilize the formation of cru-
ciform structure in plasmid pCFNO [21]. Moreover we 
employed plasmids pTA50 and pCMYC which are capa-
ble of forming intramolecular triplex and quadruplex, 
respectively (see “Methods” section). To confirm the 
presence and stabilization of these structures in superhe-
lical DNA, we tested experimentally the presence of these 
structures within the plasmid DNA using nuclease S1 
and ScaI cleavage. Our results showed a near-complete 
transition of inverted repeat into the cruciform struc-
ture in plasmid pCFNO, as suggested by practically total 
conversion of the plasmid DNA into the two fragments 
with size around 1167 and 1820 bp (Fig. 3a, lane 4). Simi-
larly, we observed a strong cleavage in pCMYC plasmid, 
suggesting the presence of quadruplex structure in a 
large part of the plasmid with natural superhelical den-
sity (Fig. 3a, lane 6). The S1 cleavage with pTA50 (Fig. 3a, 
lane 5) revealed the presence of poorly defined fragments 
relative to the cleavage of pCFNO and pCMYC plasmids. 
However, clear bands at the anticipated lengths could still 
Fig. 1 Comparison of BRCA1-L binding to different oligonucleotide 
structures. a Schematic representation of DNA substrates: SS single 
stranded, DS double stranded, Q quadruplex, CF cruciform, T triplex. 
b 5 pmol of labeled SS (lane 1–5), DS (lane 6–10), Q (lane 11–15), 
CF (lane 16–20), were incubated with increasing concentration of 
BRCA1-L (0/2.5/5/10/20 pmol) in the binding buffer (5 mM Tris–HCl, 
pH 7.0, 1 mM EDTA, 50 mM KCl and 0.01 % Triton X-100) for 15 min 
at 4 °C. Samples were electrophoresed on 8 % non-denaturating 
polyacrylamide gel at 100 V and 4 °C for 60 min
Fig. 2 BRCA1-L competition assay. a Competition gel shift assay. 
5 pmol of labeled CF was incubated with 5 pmol of BRCA1-L and 
increasing amount of competitor non-labeled DNA. Competitor 
DNAs on the image are SS single strand, lane 3–7 and Q quadruplex, 
lane 10–14. CF/Competitor DNA ratios were 1:1 (lane 3, 10), 1:2 (lane 
4, 11), 1:5 (lane 5, 12), 1:10 (lane 6, 13), 1:20 (lane 7, 14). Samples were 
incubated 15 min on ice in the binding buffer and then loaded onto 
an 8 % non-denaturating polyacrylamide gel and electrophoresed 
for 90 min at 4 °C. Arrow shows localization of the BRCA1-L/DNA 
complexes. Complexes without competitor DNA (lanes 2, 9). b Graph 
representation of the competition assay. The relative intensity of the 
BRCA1-L/DNA complexes are expressed as the percentage of the 
bands without competitor DNAs. Asterisks denote statistically signifi-
cant difference (p < 0.05) of BRCA1-L biding to non-B DNA versus DS
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be localized. It is possible that this is associated with bet-
ter accessibility of the longer SS DNA in the triplex struc-
ture by S1 nuclease. Nevertheless, it is clear that natural 
superhelical density is sufficient for triplex formation in 
at least part of the superhelical molecules.
We investigated the binding of BRCA1-L protein to dif-
ferent plasmids with the potential to form non-B DNA 
structures. The presence of all structures in superhelical 
state was demonstrated also by AFM (Fig. 4). The AFM 
images displayed linear (Fig.  4A) and also superhelical 
(Fig. 4C) plasmid DNA of pBluescript. Using Gwyddion 
software for AFM image analyses, we measured the 
size of the observed local structures and analyzed at 
least 10 molecules per structure. Plasmid pCFNO 
containing inverted repeat in the HindIII site dis-
played local expanded structures visible as small extru-
sions of 0.96  ±  0.10  nm high and with variable length 
(Fig.  4E). Plasmid pTA50 often displayed structures of 
16.9 ± 2.9 nm long and 0.98 ± 0.13 nm high correspond-
ing to the length of triplex formation from d(A)50.d(T)50 
sequence (Fig.  4G). Plasmid pCMYC showed formation 
of different structures including long blobs and spurs of 
Fig. 3 Evidence of non-B DNA structures in pCFNO, pCMYC and 
pTA50 plasmids by nuclease cleavage. The plasmids pCFNO (lane 4), 
pCMYC (lane 6) and pTA50 (lane 5) have undergone cleavage by S1 
nuclease with subsequent linearization by ScaI restriction endonucle-
ase. Supercoiled pCFNO without any digestion (lane 2) and linearized 
pCFNO by ScaI (lane 3) without S1 cleavage were used as controls. 
Bands resulting from the nuclease S1 cleavage are about 1820 and 
1167 bp. Lane 1 contains the 500 bp DNA ladder
Fig. 4 AFM images of DNA and BRCA1-L/DNA complexes. The first 
column shows the representative AFM images of different DNAs A 
linearized pBluescript, C superhelical pBluescript, E pCFNO contain-
ing cruciform structures (arrow), G pTA50 containing a triplex struc-
ture (arrow) and I pCMYC containing a quadruplex structure (arrow). 
In the second column B, D, F, H, J, the complexes of BRCA1-L with 
these plasmid DNAs are shown by arrows and are visible as white 
circular spots on the DNA strands
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1.52  ±  0.10  nm high probably corresponding to quad-
ruplex structures (Fig.  4I). The protein-DNA complexes 
were visualized under the same conditions as unbound 
DNA. BRCA1-L protein was able to bind to every kind 
of the DNA tested. The complexes of linear and super-
coiled DNAs of pBluescript are shown in Fig. 4B and D, 
respectively. The frequency of BRCA1-L/DNA complexes 
differed among various types of DNA. However, in gen-
eral, BRCA1-L protein formed complexes with linearized 
pBluescript least frequently than with supercoiled plas-
mids. Notably, supercoiled DNAs with non-B DNA 
structures were occupied by BRCA1-L protein more fre-
quently than pBluescript. Interestingly, the location of 
BRCA1-L/DNA complexes is often seen in the cross-sec-
tions of DNA strands and at the extrusions of plasmids 
(Fig. 4H, J). Furthermore, the size of the complexes varies 
from the less commonly identified monomer to the more 
frequently observed large clusters, as demonstrated in 
Fig. 4B, H and J.
Preferential binding of BRCA1‑L protein to non‑B DNA 
structures in long plasmid DNA
We analyzed BRCA1-L binding to DNA by gel shift anal-
yses on gels with 0.33× TBE buffer. Because the mobility 
of linear and superhelical DNA in 1  % agarose gel with 
0.33×  TBE buffer is nearly identical, we used immuno-
precipitation assay with magnetic beads, which is widely 
used in various assays including chromatin immunopre-
cipitation [35, 36], to compare BRCA1 protein binding 
to superhelical DNA (with non-B structure presented) 
and linear DNA (without non-B DNA structure pre-
sented). The BRCA1-L/DNA complexes were immobi-
lized onto magnetic beads coated with protein G via the 
anti-BRCA1 antibody. After magnetic separation of the 
beads from the supernatant and washing, the BRCA1-L/
DNA complexes were dissociated by heating in 0.5 % SDS 
and the recovered DNA was analyzed by agarose gel elec-
trophoresis in 1 % agarose gel with 1× TAE buffer, in the 
absence of the BRCA1-L protein. Importantly, the mobil-
ity of superhelical and linear DNA differs under such 
conditions (Fig. 5, lanes 1 and 2). In agreement with gel 
shift analyses with oligonucleotides (Figs. 1, 2), our com-
petitive immunoprecipitation assay consistently dem-
onstrated a considerable strong preference of BRCA1-L 
protein for superhelical DNA with cruciform extrusion 
compared to linear DNA which is incapable of forming 
cruciform structure. As seen in Fig. 5 (lanes 3–5), even in 
the presence of relatively high abundance of linear DNA, 
BRCA1’s preference for superhelical DNA with cruci-
form extrusion is very strong as only very weak band of 
linear DNA was precipitated by the protein. According 
to the densitometry, almost all the DNA precipitated by 
BRCA1-L protein was supercoiled DNA with cruciform 
structure extrusion. In the molar presence of superheli-
cal DNA, no more than 3 % of linear DNA was precipi-
tated by BRCA1-L protein (Fig. 5a, lane 3). Notably, even 
abundance of the linear DNA (lin:sc ratio of 2:1, Fig. 5a, 
lane 4) did not change the BRCA1-L protein’s prefer-
ence to superhelical DNA. Although the lin:sc ratio of 
4:1 lead to increased precipitation of the linear DNA, sc 
DNA remained better precipitated by BRCA1-L protein 
(Fig. 5a, lane 5). The comparison of BRCA1-L affinities to 
different DNA structures in superhelical DNA is shown 
in Fig.  5b. In all cases, the supercoiled DNA was better 
precipitated by BRCA1-L protein than linear DNA. How-
ever, the ratio of the precipitated DNA differed accord-
ing to the DNA structure presented in the plasmid DNA. 
The best target for BRCA1-L protein was pCFNO plas-
mid, followed by pCMYC, pTA50 and pBluescript. This 
result clearly revealed strong preference of the BRCA1-
L protein to non-B DNA structures that are stabilized by 
superhelical stress.
Discussion
BRCA1 is a multifunctional protein implicated in many 
important biological processes. It is a potent tumor 
suppressor and plays a major role in DNA repair and 
homologous recombination. BRCA1 protein is the most 
mutated gene in hereditary breast and ovarian cancers. 
Its mutation not only increased the lifetime risk of breast 
cancer to 65 %, but also increased the risk of other can-
cer types including prostate cancer [1]. It was shown that 
BRCA1 protein binds to DNA [7] and regulates tran-
scription of specific proteins [30]. Strong preference of 
BRCA1 protein for cruciform structure has been dem-
onstrated previously via gel shift assay on agarose gels 
[23]. It was also revealed that superhelical density could 
increase BRCA1 protein binding to DNA [9]. In this 
study we compared the binding of BRCA1 protein to DS 
DNA and non-B DNA structures and visualized these 
interactions using AFM. We showed a strong preference 
of BRCA1 protein for other non-B DNA structures such 
as quadruplex and triplex DNAs. Formation of non-B 
DNA structures is highly dependent on ion conditions, 
protein interactions and superhelical density of DNA. 
Magnesium ions are required for triplex DNA formation 
in oligonucleotide DNA, but they simultaneously inhib-
ited BRCA1-DNA binding. Interestingly, we observed 
BRCA1 protein binding to DNA structures in plasmid 
DNA where these structures are stabilized by DNA 
supercoiling. Our results thereby demonstrated that 
native superhelical density is sufficient for non-B DNA 
structure formation. Furthermore, an array of experi-
mental methods, including chromatin immunoprecipi-
tation, confocal microscopy and functional assays, have 
illustrated that these structures are presented broadly 
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in cells, with epigenetic modification being a potential 
mechanism of complex cell regulation. The presence of 
the magnesium could be an important factor which ena-
bles the formation of different DNA structures in cells 
[32, 33]. It was demonstrated that magnesium stabi-
lizes DNA structures and plays a role in many enzymes’ 
catalytic action [34]. Even if the amount of magnesium 
in the cell is relatively high compare to other ions, the 
concentration of free magnesium is in fact low and most 
Mg2+ ions are bound to ATP, proteins and other cellular 
components [35]. Moreover, overexposure to magnesium 
is toxic [36]. It was also noted that bivalent ion influences 
the DNA binding of other protein greatly [37]. It is likely 
that tight regulation of the magnesium in the cell allows 
optimal BRCA1 DNA binding in living cells.
It has been revealed that BRCA1 protein plays a key 
role in homology-directed repair of DNA double strand 
breaks [38, 39] and facilitates end joining of DNA breaks 
[40]. Interestingly, certain local DNA structures could 
be the source of the DNA breaks [41]. Local DNA struc-
tures are known to facilitate different cellular processes 
including telomere length regulation, transcriptional 
modification, DNA replication and other events of cell 
maintenance. Hence, BRCA1’s ability to interact with 
these structures could be essential for cell survival and 
regulation. Over the last couple of years, it has brought 
to attention that non-B DNA structures, especially quad-
ruplexes, are critical for transcriptional regulation of 
different genes including c-Myc proto-oncogene [14]. 
The presence of G-quadruplexes is also evident in many 
important gene promoters such as Kras, Kit and TERT 
[42] and a large number of proteins have been character-
ized with preferential binding to these quadruplexes [43]. 
It was reported that BRCA1 protein regulates telomerase 
and 3′ overhang length of telomeres [44]. Importantly, 
BRCA1 protein interacts directly with human telomeres. 
This is established by telomeric ChIP assay and confo-
cal microscopy, showing co-localization of the BRCA1 
Fig. 5 Comparison of the BRCA1-L protein binding to supercoiled and linear DNA by magnetic immunoprecipitation. a 0.3 μg superhelical pCFNO 
(lanes 3–5) and increased concentration of linear pCFNO/XhoI (0.3 μg—lane 3, 0.6 μg—lane 4, 1.2 μg—lane 5) were incubated with BRCA1-L protein 
(protein:DNA molar ratio 20:1) in binding buffer (5 mM Tris, 2 mM dithiothreitol 50 mM KCl, 0.01 % Triton X-100) with magnetic beads modified by 
the addition of BRCA1 monoclonal antibodies. BRCA1-DNA complexes were disrupted in a final step by incubation with 0.5 % SDS at 65 °C and 
then electrophoresed on 1 % agarose gel at 120 V and room temperature for 45 min. Lanes 1 and 2 contain control DNA of superhelical pCFNO and 
linear pCFNO/XhoI, respectively. b Graph representation of the BRCA1-L magnetic immunoprecipitation with different DNA targets. Ratio of the 
supercoiled and linear DNA before precipitation was 1:1. Densitometry of the DNA bands after immunoprecipitation with the BRCA1-L protein is 
shown in bar. c Scheme of the immunoprecipitation followed by DNA detection on magnetic beads
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protein with telomeric DNA in cultured cells [45]. 
Recently it was observed that BRCA1 mutation carriers 
have longer telomeres than their non-mutation carriers 
[46]. Moreover, BRCA1 is repeatedly absent or signifi-
cantly decreased in sporadic breast cancer [47]. Given 
BRCA1 protein’s newly identified role in telomere regu-
lation [45], its preferential binding to quadruplex DNA 
may indicate an important role in processes that are asso-
ciated with quadruplex formation in the genome.
Conclusion
It is well understood that BRCA1 protein binds to dam-
aged DNA and plays a role in transcriptional regulation 
of downstream target genes. However, BRCA1-DNA 
binding properties to local DNA structures have not 
yet been reported in detail. Our study suggests a strong 
influence of non-B DNA structures on BRCA1-DNA 
interactions. These findings propose a novel perspective 
on the understanding of how BRCA1 protein regulates 
various tasks through direct interaction with DNA. The 
ability of BRCA1 protein to bind preferentially to topo-
logically folded non-B DNA further hinted the value of 
these structures not only in transcriptional regulation, 




Synthetic oligonucleotides with and without FAM-3′-end 
labeling were purchased from IDT, Inc. The oligonucleo-
tide sequences and annealing buffers of single-stranded, 
double-stranded, cruciform, triplex and quadruplex 
DNAs are described in Additional file   1: Figure S3 
(schema of DNA structures, Fig. 1a). Complementary oli-
gonucleotides were annealed by incubation at 95  °C for 
5 min with subsequent cooling to 4 °C at a rate of 1 °C/
min. Oligonucleotide for quadruplex formation was incu-
bated at room temperature for 16 h.
Plasmid DNA
Supercoiled plasmid DNAs of pBluescript II SK (−), 
and derived plasmids pCFNO [48], pCMYC and pTA50 
were isolated from bacterial strain DH5α as described 
in the QIAGEN protocol (QIAGEN GmbH, Germany). 
XhoI restriction enzyme (New England Biolabs, UK) 
was used for linearization of plasmids. pCMYC plasmid 
was constructed by cloning the 141  bp  EcoRI/HindIII 
restriction fragment of pNHE plasmid [49] into the 
EcoRI/HindIII site of pBSK. pTA50 plasmid was con-
structed by cloning of (dT)50.(dA)50 sequence,  forming 
a DNA triplex, into the EcoRV site of pBSK. Plasmids 
pCMYC and pTA50 were kindly provided by Dr. Marie 
Brazdova.
BRCA1 protein constructs
The coding region for the central region of BRCA1 pro-
tein (BRCA1-A, aa 219–498 and BRCA1-L, aa 444–1057) 
was PCR amplified from human BRCA1 cDNA, sub-
cloned into the pET15b expression vector (Novagen), 
expressed, and purified as described [9].
Gel electrophoretic mobility shift assays on polyacrylamide 
gels
Labeled oligonucleotides (5  pmol) and BRCA1 pro-
tein constructs were mixed at different molar ratios 
(1:0.5/1/2/4) in 20 μl of the DNA binding buffer (5 mM 
Tris–HCl, pH 7.0, 1 mM EDTA, 50 mM KCl and 0.01 % 
Triton X-100). Competition assay contains increas-
ing amount of competitor DNA (5/10/25/50 pmol) with 
5 pmol of labeled cruciform oligonucleotide and 5 pmol 
of BRCA1-L protein in 20 μl of the DNA binding buffer. 
The samples were incubated for 15  min at 4  °C and 
loaded onto an 8 % non-denaturating polyacrylamide gel 
containing 0.33× Trisborate-EDTA buffer. Electrophore-
sis was performed for 60 min at 100 V at 4  °C. The gels 
were visualized on a LAS-3000 image analyzer (Fujifilm) 
and processed digitally.
Statistical analysis
The relative intensity of the BRCA1-L/DNA complexes is 
presented as the percentage of the bands without com-
petitor DNAs. Data were analyzed by non-parametric 
methods to avoid assumptions about the distribution of 
the measured variables. Comparisons between groups 
were made with the Mann–Whitney U test (Statistica 
software). All values are reported as mean ± SD. Statisti-
cal significance was considered to be indicated by a value 
of p < 0.05.
Proof of the non‑B DNA structures in plasmids by S1 
nuclease cleavage
2 µg of plasmid DNA was digested by S1 nuclease (New 
England Biolabs, UK; 2  U/μg DNA) for  2  h at 37  °C in 
the S1 nuclease buffer (30  mM sodium acetate pH 4.6, 
280  mM NaCl, 1  mM·ZnSO4). After digestion, sam-
ples were precipitated in ethanol, dissolved in water and 
digested by ScaI (New England Biolabs, UK) for 1  h at 
37 °C before separation by electrophoresis on 1 % agarose 
gel.
Atomic force microscopy
BRCA1-L protein and 200  ng of plasmid DNA were 
mixed in a molar ratio of 20:1 in the binding buffer 
[(50  mM KCl, 5  mM Tris, 0.05  mM EDTA, 0.01  % Tri-
ton X-100), final volume 10  μl] and incubated on ice 
for 15  min. AFM imaging was performed on Grade V4 
mica discs (SPI supplies, USA). The DNA samples and 
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protein-DNA complexes were deposited on mica in a 
buffer containing 5 mM Na-Hepes pH 7.5, 20 mM KCl, 
10 mM MgCl2,10 mM Tris in the concentration of 1 ng/
μl DNA and incubated for 5 min, followed by rinsing with 
deionized water and air-dried. The images were obtained 
using AFM/STM Multimode eight electrochemical sys-
tem, (Veeco, USA), operating in ScanAsyst mode in 
room temperature in air. The cantilever SCANASYST-
AIR (Bruker) had a nominal spring constant of 0.4 N/m 
and the nominal scanning rate was set as 1 Hz. Obtained 
images were then analyzed using Gwyddion software 
package [50].
Competition assay by immunoprecipitation on magnetic 
beads
Superhelical and linear plasmids were incubated with 
protein G-coated magnetic beads (Dynabeads) using 
immobilized BRCA1-L immune complex with the anti-
BRCA1 polyclonal antibody (Abcam) in the binding 
buffer. The samples were shaken gently for 30  min at 
10  °C and then washed 3 times with the binding buffer. 
The BRCA-L/DNA complexes were disrupted by incuba-
tion with 0.5 % SDS for 5 min at 65 °C. The samples were 
loaded on a 1 % agarose gel containing 1x TAE (Tris–ace-
tate-EDTA) buffer (Fig. 5).
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